Jul 2026
Integrative analysis identifies candidate biomarkers for bladder cancer: evidence from genomic and clinical validation
It is suggested that PAFAH1B3 and PSMG3 may serve as valuable biomarkers and potential therapeutic targets in bladder cancer, however, further investigations are needed to establish their biological function and clinical relevance.
Sana Sajjadi, Amin Ramezani, S. Alavimanesh et al.
· Molecular Biology Reports · 0 citations